Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Submit Manuscript
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Topic/Program Collections
    • Blog
  • Multimedia
    • Teaching Slides
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors
    • Submit Manuscript
    • Author Guidelines
  • Content
    • Current Issue
    • Complete Issue PDF
    • Archive
    • Topic/Program Collections
    • Blog
  • Multimedia
    • Teaching Slides
    • Pediatrics On Call Podcast
  • CME/MOC
    • CME Quizzes
    • MOC Claiming
  • Subscribe
  • Alerts
  • Careers
American Academy of Pediatrics
Article

Coagulation Disorders

Janna M. Journeycake and George R. Buchanan
Pediatrics in Review March 2003, 24 (3) 83-91; DOI: https://doi.org/10.1542/pir.24-3-83
Janna M. Journeycake
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George R. Buchanan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Comments
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Download PDF
  1. Janna M. Journeycake, MD*
  2. George R. Buchanan, MD*
  1. *Division of Hematology-Oncology, Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, and the Center for Cancer and Blood Disorders at Children’s Medical Center of Dallas, Dallas, TX
  • APCR: activated protein C resistance
  • AT: antithrombin
  • DDAVP: desmopressin acetate
  • DIC: disseminated intravascular coagulation
  • DVT: deep vein thrombosis
  • F: factor
  • INR: International Normalized Ratio
  • LA: lupus anticoagulant
  • LMWH: low-molecular weight heparin
  • PC: protein C
  • PFA: platelet function analyzer
  • PS: protein S
  • PT: prothrombin time
  • PTT: partial thromboplastin time
  • TF: tissue factor
  • vWD: von Willebrand disease
  • vWF: von Willebrand factor

Objectives

After completing the article, readers should be able to:

  1. Determine when factor replacement should be given to patients who have hemophilia.

  2. Describe the major long-term problems for hemophilia patients.

  3. List the variables that affect von Willebrand factor measurements.

  4. Delineate the most common risk factor for the development of deep vein thrombosis in children.

  5. Characterize the normal range of coagulation proteins according to age.

Introduction

Hemostasis is a process by which the body repairs damage to a blood vessel wall to prevent hemorrhage. At the site of injury, a hemostatic plug is formed by the interaction of the vessel wall, platelets, and coagulation factors. As the plug is formed, the coagulation system generates thrombin from prothrombin, thus initiating the formation of a fibrin clot (Fig. 1). This system is well controlled by multiple modulators and inhibitors at each step in the pathway. The major trigger for coagulation is the exposure of tissue factor (TF) in the injured vessel wall. TF binding to Factor VII (FVII), along with calcium and platelet-derived phospholipids, activates FX. FX, in conjunction with FV, prothrombin, calcium, and phospholipids, generates thrombin. Thrombin can initiate further thrombin production by the contact factor cascade (intrinsic pathway). It also converts fibrinogen to fibrin and activates FXIII to crosslink and stabilize fibrin. There are several inhibitors of this coagulation mechanism. Antithrombin (AT), heparin cofactor II, and alpha-2-macroglobulin directly neutralize the activity of thrombin. Protein C (PC), protein S (PS), and endothelial-bound thrombomodulin indirectly inhibit thrombin generation by inactivating FV and FVIII. A disorder of hemostasis can be manifested by either bleeding or thrombosis.

Figure 1.

The coagulation system. F=factor, TF=tissue factor.

The hemostatic system is dynamic throughout childhood. Specifically, the concentrations of the vitamin K-dependent proteins (FII, FVII, FIX, FX) and contact factors (FXII, high-molecular weight kininogen, prekallikrein) are reduced in the first 6 months …

Individual Login

Log in
You will be redirected to aap.org to login or to create your account.

Institutional Login

via Institution

You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Offer Reprints

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics in Review: 24 (3)
Pediatrics in Review
Vol. 24, Issue 3
1 Mar 2003
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Coagulation Disorders
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Coagulation Disorders
Janna M. Journeycake, George R. Buchanan
Pediatrics in Review Mar 2003, 24 (3) 83-91; DOI: 10.1542/pir.24-3-83

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Coagulation Disorders
Janna M. Journeycake, George R. Buchanan
Pediatrics in Review Mar 2003, 24 (3) 83-91; DOI: 10.1542/pir.24-3-83
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
    • Objectives
    • Introduction
    • Bleeding Disorders
    • Hemophilia
    • von Willebrand Disease
    • Uncommon Bleeding Disorders
    • Acquired Bleeding Disorders
    • Thrombotic Disorders
    • Thrombophilia
    • Diagnosis, Treatment, and Long-term Considerations of Thrombotic Disease
    • Conclusion
    • Suggested Reading
  • Figures & Data
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Consultative hematology I: hospital-based and selected outpatient topics
  • Google Scholar

More in this TOC Section

  • Review of Scabies Infestation and Selected Common Cutaneous Infections
  • Pediatric Ingestions: New High-Risk Household Hazards
  • Iron Deficiency: Implications Before Anemia
Show more Article

Similar Articles

Subjects

  • Genetics
    • Genetics
  • Fetus/Newborn Infant
    • Fetus/Newborn Infant
  • Hematology/Oncology
    • Blood Disorders
  • Journal Info
  • Editorial Board
  • ABP Content Specifications Map
  • Overview
  • Licensing Information
  • Authors
  • Author Guidelines
  • Submit My Manuscript
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
American Academy of Pediatrics

© 2021 American Academy of Pediatrics